期刊文献+

微生物转化洛伐他汀条件的初步研究 被引量:2

Preliminary studies on conditions for microbial conversion of lovastatin
在线阅读 下载PDF
导出
摘要 以本实验室筛出的一株菌ST2 710为出发菌 ,研究不同培养条件对转化率的影响。结果发现 ,菌株ST2 710在种子培养基进行预培养 ,再转入转化培养基中培养 2d后 ,加入洛伐他汀溶液 1.0mL(10mg/mL)后再培养 5d ,产物的产率可达 4 3.4 1% ;就四种溶剂溶解底物条件进行了研究 ,结果发现用二甲基甲酰胺溶解洛伐他汀 ,产物产率为最高 ,并且转化作用不需要底物的诱导 ; The optimal medium and the fermentation conditions of converting lovastatin by strain ST2710 were investigated. The results showed that strain ST2710 was preinoculated in seed media for two days, then 1mL of the seed culture was incubated into biotransformation media. After two days of growth, 1.0mL of calibration lovastatin was added and the incubation was continued for another five days. The productivity was 43.41%. The effects of different organic solvents on productivity were also investigated. And it was found the system of bioconversion required no induction with lovastatin; the rate of bioconversion with suspended cells was better than that with washed mycelium or the broth.
出处 《工业微生物》 CAS CSCD 北大核心 2003年第4期17-19,共3页 Industrial Microbiology
关键词 微生物 转化条件 发酵条件 产率 lovastatin bioconvertion fermentation condition
  • 相关文献

参考文献7

  • 1Akira Endo.The discovery and development of HMG-CoA reductase inhibitors.J Lipid Res 1992,33:1569~1582
  • 2N.Serizawa,S.Serizawa,K.Nakagawa et al.Microbial hydroxylation of ML-236B(compactin)and monacolin K(MB-530B).J Antibioties.1983,36:604~607
  • 3A.Jekkel,A.Konya,E.Ilkoy et al.Microbial comversion of mevinolin.J Antibiotics.1997,50(9):750~754
  • 4Arnold L.Demain,Julian Davies,Ronald Atlas et al.Manual of Industrial Microbiology and Biotechnology,2nd ed,America:ASM PRESS,1999.165~180
  • 5T.Matsuoka,S.Miyakoshi,K.Tanzawa,et al.Purification and characterization of cytochrome P-450sca from Streptomyces carbophilus.EurJ Biochem.1989,184:707~713
  • 6N.Serizawa,T.Matsuoka.A two component-type cytochrome P450 monooxygenase system in a prokaryote that catalyzes hydroxylation of ML-236B to pravastatin,a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.Biochim Biophys Acta.1991,1084:35~40
  • 7Yulin Peng,Arnold L.Demain.Bioconversion of compactin to pravastatin by Actinomadure sp.ATCC 55678.Journal of Molecular Catalysis B:Enzymatic 2000,10:151~156

同被引文献19

  • 1Elizabeth GN.Cardiovascular disease.The New England Journal of Medicine.2003,349 (1):60~72.
  • 2Mukesh K J,Ridker P M.Nature Reviews Drug Discovery 2005,4(12):977~987.
  • 3Marcin C,White R,Hirsch F,et al.Bioconversion of the sodium salt of simvastatin (MK-733) to 6-desmethyl-6-hydroxymethyl simvastatin.Journal of Industrial Microbiology,1991,8:157~164.
  • 4Serizawa N,Nakagawa K,Hmano K.et al.Microbial hydroxylation of ML-236B (compactin) and monacolin K (MB2530B).J Antibiotics.1983,36:604~607.
  • 5Ferris F,Michael J.Process for the preparation of 6-alphahydroxymethyl lovastatin derivatives[P].European Patent Application 0381478,1990,28:81~86.
  • 6Jekkel A,Konya A,Ilkoy E,et al.Microbial conversion of mevinolin.J Antibiotics.1997,50(9):750~754.
  • 7诸葛健,方慧英,于海.一种拟无枝酸菌及其生物转化洛伐他汀为无锡他汀的技术[P],中国专利,200410044893.2004-5-31.
  • 8Klingenberg,M.Pigments of rat liver microsomes.Arch.Biochem.Biophys.1958,75:376~386.
  • 9Omura,T.and Sato,R.A new cytochrome in liver microsomes.J.Biol.Chem.1962,237:1375~1376.
  • 10Park J-W,Lee J-K,Kwon T-J,et al.Purification and characterization of a cytochrome P-450 from pravastatin-producing Streptomyces sp.Y-110.J Microbiol Biotechnol,2001,11(6):1011~1017.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部